Cargando…
Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal Symptoms
The correct balance between reactive oxygen species and antioxidant defense in an organism is disturbed in oxidative stress. To assess oxidative balance in 36 SSc patients and 26 healthy controls (HCs), we measured reactive oxidative metabolites (ROMs), total antioxidant capacity (TAC), lipid peroxi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452464/ https://www.ncbi.nlm.nih.gov/pubmed/37626607 http://dx.doi.org/10.3390/biomedicines11082110 |
_version_ | 1785095677686054912 |
---|---|
author | Brezovec, Neža Perdan-Pirkmajer, Katja Burja, Blaž Rotar, Žiga Osredkar, Joško Sodin-Šemrl, Snežna Lakota, Katja Čučnik, Saša |
author_facet | Brezovec, Neža Perdan-Pirkmajer, Katja Burja, Blaž Rotar, Žiga Osredkar, Joško Sodin-Šemrl, Snežna Lakota, Katja Čučnik, Saša |
author_sort | Brezovec, Neža |
collection | PubMed |
description | The correct balance between reactive oxygen species and antioxidant defense in an organism is disturbed in oxidative stress. To assess oxidative balance in 36 SSc patients and 26 healthy controls (HCs), we measured reactive oxidative metabolites (ROMs), total antioxidant capacity (TAC), lipid peroxidation (measuring 4-HNE), and DNA oxidative damage (measuring 8-OHdG) in serum. Furthermore, DNA breaks in leukocytes of 35 SSc patients and 32 HCs were evaluated using COMET. While we report high ROMs for both SSc patients and age/sex matched HC samples, there was a significant increase in TAC in SSc patients as compared to HCs, and thus also a significantly higher oxidative stress index in SSc patients. TAC was significantly higher in SSc patients with ILD and gastrointestinal involvement, as well as in patients with anti-topoisomerase antibodies. We observe no difference in serum lipid peroxidation status or oxidative DNA damage. However, SSc patients had significantly more leukocyte DNA breaks than HCs; the most damage was observed in patients treated with immunosuppressives. Thus, our study confirms presence of oxidative stress and increased DNA damage in leukocytes of SSc patients; however, it points toward increased antioxidant capacity, which needs to be further studied. |
format | Online Article Text |
id | pubmed-10452464 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104524642023-08-26 Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal Symptoms Brezovec, Neža Perdan-Pirkmajer, Katja Burja, Blaž Rotar, Žiga Osredkar, Joško Sodin-Šemrl, Snežna Lakota, Katja Čučnik, Saša Biomedicines Article The correct balance between reactive oxygen species and antioxidant defense in an organism is disturbed in oxidative stress. To assess oxidative balance in 36 SSc patients and 26 healthy controls (HCs), we measured reactive oxidative metabolites (ROMs), total antioxidant capacity (TAC), lipid peroxidation (measuring 4-HNE), and DNA oxidative damage (measuring 8-OHdG) in serum. Furthermore, DNA breaks in leukocytes of 35 SSc patients and 32 HCs were evaluated using COMET. While we report high ROMs for both SSc patients and age/sex matched HC samples, there was a significant increase in TAC in SSc patients as compared to HCs, and thus also a significantly higher oxidative stress index in SSc patients. TAC was significantly higher in SSc patients with ILD and gastrointestinal involvement, as well as in patients with anti-topoisomerase antibodies. We observe no difference in serum lipid peroxidation status or oxidative DNA damage. However, SSc patients had significantly more leukocyte DNA breaks than HCs; the most damage was observed in patients treated with immunosuppressives. Thus, our study confirms presence of oxidative stress and increased DNA damage in leukocytes of SSc patients; however, it points toward increased antioxidant capacity, which needs to be further studied. MDPI 2023-07-26 /pmc/articles/PMC10452464/ /pubmed/37626607 http://dx.doi.org/10.3390/biomedicines11082110 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Brezovec, Neža Perdan-Pirkmajer, Katja Burja, Blaž Rotar, Žiga Osredkar, Joško Sodin-Šemrl, Snežna Lakota, Katja Čučnik, Saša Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal Symptoms |
title | Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal Symptoms |
title_full | Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal Symptoms |
title_fullStr | Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal Symptoms |
title_full_unstemmed | Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal Symptoms |
title_short | Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal Symptoms |
title_sort | disturbed antioxidant capacity in patients with systemic sclerosis associates with lung and gastrointestinal symptoms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452464/ https://www.ncbi.nlm.nih.gov/pubmed/37626607 http://dx.doi.org/10.3390/biomedicines11082110 |
work_keys_str_mv | AT brezovecneza disturbedantioxidantcapacityinpatientswithsystemicsclerosisassociateswithlungandgastrointestinalsymptoms AT perdanpirkmajerkatja disturbedantioxidantcapacityinpatientswithsystemicsclerosisassociateswithlungandgastrointestinalsymptoms AT burjablaz disturbedantioxidantcapacityinpatientswithsystemicsclerosisassociateswithlungandgastrointestinalsymptoms AT rotarziga disturbedantioxidantcapacityinpatientswithsystemicsclerosisassociateswithlungandgastrointestinalsymptoms AT osredkarjosko disturbedantioxidantcapacityinpatientswithsystemicsclerosisassociateswithlungandgastrointestinalsymptoms AT sodinsemrlsnezna disturbedantioxidantcapacityinpatientswithsystemicsclerosisassociateswithlungandgastrointestinalsymptoms AT lakotakatja disturbedantioxidantcapacityinpatientswithsystemicsclerosisassociateswithlungandgastrointestinalsymptoms AT cucniksasa disturbedantioxidantcapacityinpatientswithsystemicsclerosisassociateswithlungandgastrointestinalsymptoms |